Immunotherapy at ASCO 2023: updates in neoadjuvant and adjuvant therapy

ASCO Guideline Recommendation Highlights for Systemic Therapy for MelanomaПодробнее

Updates on Neo adjuvant and Adjuvant Chemo immunotherapy - Rajwanth VeluswamyПодробнее

The personalization of neoadjuvant immunotherapy in stage III melanomaПодробнее

Melanoma Updates from ASCO 2023 SymposiumПодробнее

Practice-Changing Updates from IASLC: 2023 Review and Renew Lake TahoeПодробнее

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John HeymachПодробнее

Case-based clinical update in Lung Cancer | 2023 Community Cases MemphisПодробнее

Immunotherapy in CRC | 2023 Best of GI Cancer ConferenceПодробнее

Gastric and Esophageal Cancer | 2023 Best of GI Cancer ConferenceПодробнее

Updates in colorectal and rectal cancer at ASCO GI 2023Подробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Ask the Expert - A Year in Review: 2022 Research Updates for the Melanoma CommunityПодробнее

The Future of Melanoma: What to Anticipate in 2023 with Neoadjuvant and Adjuvant PembrolizumabПодробнее

New Treatments in Melanoma and Non-Melanoma​ Skin CancerПодробнее

Updates in Rectal CancerПодробнее